Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Notox gets buzzed by NAD

This article was originally published in The Tan Sheet

Executive Summary

Statements that "clinical test results show that Notox...combats the effects of alcohol intoxication" should be modified, the National Advertising Division tells A.D. Pharma following a recent review. Implied and explicit claims on TV, radio, and print ads and testimonials for the Panax ginseng/citrus reticulate supplement, found during routine monitoring, are not supported by a trial in 10 male subjects, the watchdog group adds. NAD also was troubled by claims that could lead consumers to believe that "Notox allows product users to drink and drive." A.D. Pharma said it modified the television spot prior to NAD's inquiry, and plans on revising its website...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096775

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel